Background: The role of glucocorticoids in extinction of traumatic memories has not been fully characterized despite its potential as a therapeutic target for acquired posttraumatic stress disorder (PTSD). The predator stress paradigm allows us to determine whether glucocorticoids mediate the extinction of both context-dependent and context-independent fear memories. Methods: Male C57BL/6J mice were exposed to a predator (cat) then repeatedly exposed to the predator stress context in the absence of the cat. Context-dependent (associative) fear memory was assessed as suppression of activity during re-exposure to the predator stress context without the cat (extinction trials). Context-independent fear (non-associative) was assessed seven days after extinction trials using measures of hyperarousal and anxiety-like behaviours in environments unlike the predator stress context. To assess the role of glucocorticoids, mice were injected with metyrapone (50 mg/kg) 90 min prior to extinction trials in predator stressed mice and context-dependent and context-independent fear memories were assessed. Finally, metyrapone-treated predator stressed mice were injected with corticosterone (5 or 10 mg/kg) immediately following extinction trials and context-dependent and context-independent fear memories were assessed. Results: Repeated re-exposure to the predator stress context without the cat present extinguished context-dependent fear memory, and also reduced hyperarousal, a generalized, chronic PTSD-like symptom. We show that extinction of context-independent predator stress-induced hyperarousal is dependent on endogenous glucocorticoids during the extinction trials. Furthermore, the inhibition of extinction by metyrapone on startle amplitude was reduced by exogenous administration of corticosterone following extinction trials. Overall, these data implicate glucocorticoids in the extinction of hyperarousal, a core symptom of PTSD.
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Introduction
Exposure to severe stressors such as a traumatic physical or psychological experience may result in the development of affective disorders. One such disorder, posttraumatic stress disorder (PTSD), is characterized by persistent re-experiencing of the trauma, avoidance of trauma-associated stimuli, a general numbing of emotion, and hyperarousal (DSM-IV-TR, 309.81). Between 6.8% and 15% of North Americans develop PTSD following a traumatic event (Kessler et al., 2005) . The importance of studying PTSD has increased with the recent terrorist attacks such as September 11, 2001 in New York, which increased prevalence of PTSD (Galea et al., 2008; Kessler & Wang, 2008) .
Treatments for acquired anxiety disorders such as PTSD often rely on progressive extinction of fear memories (Bentz, Michael, de Quervain, & Wilhelm, 2010) . Unfortunately, the inability to extinguish intense fear memories is an important clinical problem in psychiatric disorders such as PTSD (Blechert, Michael, Grossman, Lajtman, & Wilhelm, 2007; Blechert, Michael, Vriends, Margraf, & Wilhelm, 2007; Yang, Chao, & Lu, 2006) . Thus, the purpose of this set of experiments is to use an animal model of PTSD to identify factors that modulate progressive extinction of fear memories produced by severe stress. Knowledge of such factors may suggest more effective extinction treatments.
There is growing evidence from both rodent and human studies that glucocorticoids (corticosterone in animals and cortisol in humans) play a key role in distinct fear memory processes. Glucocorticoids can dose-dependently enhance the consolidation of new fear memoires (Abercrombie, Kalin, Thurow, Rosenkranz, & Davidson, 2003; McGaugh & Roozendaal, 2002; Okuda, Roozendaal, & McGaugh, 2004; Roozendaal, 2002; Sandi & Rose, 1994) . On the other hand, pharmacological blockade of corticosterone or cortisol synthesis with metyrapone impairs memory consolidation in both animals and humans (Maheu, Joober, Beaulieu, & Lupien, 2004; Roozendaal, Bohus, & McGaugh, 1996) . As in
